Star Therapeutics is a clinical-stage biotechnology company focused on discovering and developing novel antibodies for the treatment of bleeding disorders and other diseases. Its lead program, VGA039, is an innovative antibody targeting Protein S to restore blood clotting balance, currently undergoing a pivotal Phase 3 trial for von Willebrand Disease.
Leadership & Board
Current Number of Employees46
Current LinkedIn Followers5,308
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$125M
Total Amount Raised$125M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$125M
Latest Funding Amount$125M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Star Therapeutics had 46 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
46Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Star Therapeutics had 5,308 followers as of October 5, 2026. The number of followers increased by 14 (0.26%) week-over-week.
5,308Latest Followers Count
14(0.26%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.